Phase II single arm trial of aflibercept in patients with recurrent temozolomide-resistant glioblastoma: NABTC 0601 Other Scholarly Work

De Groot, JF, Wen, PY, Lamborn, K et al. (2008). Phase II single arm trial of aflibercept in patients with recurrent temozolomide-resistant glioblastoma: NABTC 0601 . JOURNAL OF CLINICAL ONCOLOGY, 26(15), 10.1200/jco.2008.26.15_suppl.2020

cited authors

  • De Groot, JF; Wen, PY; Lamborn, K; Chang, S; Cloughesy, TF; Chen, AP; DeAngelis, LM; Mehta, MP; Gilbert, MR; Yung, WK; Prados, MD

sustainable development goals

authors

publication date

  • May 20, 2008

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

volume

  • 26

issue

  • 15